Australian Government Will Not Suspend Use of mRNA Covid-19 Vaccines
he Australian government says it will not suspend the use of mRNA Covid-19 vaccines, despite warnings from several high-profile scientists that the products could increase the risk of cancer.
Russell Broadbent, the Member for Monash, along with 52 doctors, lawyers, academics, and politicians, wrote a letter to the Prime Minister, urging the immediate suspension of the vaccines.
The Prime Minister passed the letter to Health Minister Mark Butler, who then delegated it to his Chief of Staff, Nick Martin, to prepare a response.
In the letter, Martin stated, “For a decision maker to make such a large impactful decision that would unduly worry Australians, the evidence relied upon must be legally, scientifically, and clinically sound.”
Martin concluded that the evidence presented to the PM’s office did “not support such a large and important decision.”
This stance comes in the wake of several independent studies reporting excessive levels of residual DNA in vaccines, which have the potential to integrate into the human genome and lead to mutations, known as ‘insertional mutagenesis.’
Canadian virologist David Speicher found that residual DNA levels in three Australian vials, including one intended for children, exceeded the regulatory limit of 10 nanograms by up to 145 times.
The letter from Butler’s office also stated, “The overwhelming evidence is that the mRNA vaccines have saved lives and have acceptable safety profiles,” referencing the position of the International Coalition of Medicines Regulatory Authorities (ICMRA).
However, ICMRA emphasises that its member countries should uphold robust safety monitoring systems, which continuously collect and analyse reports of suspected harms – an area where the regulator has evidently fallen short.
Moreover, a key aspect of ICMRA’s stance that appears to have been conveniently overlooked by Butler’s office is their call for the pharmaceutical industry to provide access to clinical data for all new vaccines and to publish clinical trial reports without redacting confidential information, citing overriding public health interest.
Broadbent said he was “disappointed but not surprised” by the dismissive response from Butler’s office.
He said, “I’ve been writing to the Health Minister and Prime Minister for several years now, and there has been a total lack of willingness to engage on the issues I’ve raised.”
Read More – Australian Government Will Not Suspend Use of mRNA Covid-19 Vaccines
